Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448.

Autor: Cohen PA; Department of Gynaecological Oncology, Bendat Family Comprehensive Cancer Centre, St John of God, 12 Salvado Rd, Subiaco, Western Australia 6008, Australia; Division of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Western Australia, 35 Stirling Highway, Crawley,Western Australia 6009, Australia; Institute for Health Research, The University of Notre Dame Australia, 32 Mouat Street, Fremantle, Western Australia 6160, Australia. Electronic address: Cohen@uwa.edu.au., Powell A; Division of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Western Australia, 35 Stirling Highway, Crawley,Western Australia 6009, Australia; Institute for Health Research, The University of Notre Dame Australia, 32 Mouat Street, Fremantle, Western Australia 6160, Australia., Böhm S; Department of Medical Oncology, Barts Health NHS Trust,West Smithfield, London EC1A 7BE, United Kingdom., Gilks CB; Department of Anatomic Pathology, Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada., Stewart CJR; Department of Histopathology, King Edward Memorial Hospital, 374 Bagot Road, Subiaco, Western Australia 6008, Australia., Meniawy TM; School of Medicine and Pharmacology, The University ofWestern Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Gairdner Drive, Nedlands, Western Australia 6010, Australia., Bulsara M; Institute for Health Research, The University of Notre Dame Australia, 32 Mouat Street, Fremantle, Western Australia 6160, Australia., Avril S; Department of Pathology, School ofMedicine, CaseWestern Reserve University, University Hospitals ClevelandMedical Center and Case Comprehensive Cancer Center,Wolstein Research Building, Room 6524, 2103 Cornell Road, Cleveland, OH 44106, United States; Institute of Pathology, Technische Universität München, Ismaninger Str. 22, Munich 81675, Germany., Brockbank EC; Department of Gynaecological Oncology, Barts Health NHS Trust, Whitechapel Rd, London E1 1BB, United Kingdom., Bosse T; l Department of Pathology, Leiden University Medical Centre, Albinusdreef 2, PO Box 9600, 2333, ZA, Leiden, The Netherlands., de Azevedo Focchi GR; Department of Pathology, Federal University de São Paulo (UNIFESP), R Botucatu, 740, São Paulo, SP CEP 04023-062, Brazil., Ganesan R; Department of Cellular Pathology, Birmingham Women's NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2TG, United Kingdom., Glasspool RM; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom., Howitt BE; Department of Pathology, School of Medicine, Stanford University, 300 Pasteur Drive, H2128E, Stanford, CA 94305, United States., Kim HS; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea., Lee JY; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea., Le ND; Cancer Control Research, British Columbia Cancer Research Centre, 675West 10th Ave, Vancouver, BC V5Z1L3, Canada., Lockley M; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom; University College London Hospital, 235 Euston Rd, Fitzrovia, London NW1 2BU, United Kingdom., Manchanda R; Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, 10th Floor, South Block, Whitechapel Road, London E1 1BB, United Kingdom., Mandalia T; Department of Histopathology, Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital (Wonford), Old Pathology Building, Church Lane, Exeter, Devon EX2 5AD, United Kingdom., McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Grosvenor Road, Belfast BT12 6BA, United Kingdom., McNeish I; Division of Cancer, Department of Surgery and Cancer, Imperial College London, IRDB Building, Hammersmith Hospital, London W12 0NN, United Kingdom., Midha D; Department of Pathology, Tata Medical Center, Kolkata, 14 MAR, Rajarhat, Kolkata 700160, India., Srinivasan R; Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India., Tan YY; Department of Medical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom., van der Griend R; Department of Anatomical Pathology, Canterbury Health Laboratories, 2 Riccarton Ave, Christchurch 8011, New Zealand., Yunokawa M; Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Zannoni GF; Department of Pathology, Women and Child Health, Fondazione Policlinico Gemelli, Università Cattolica del Sacro Cuore, Largo F Vito 1, 00168 Roma, Italy., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, Whitechapel Rd, London E1 1BB, United Kingdom.
Jazyk: angličtina
Zdroj: Gynecologic oncology [Gynecol Oncol] 2021 Apr; Vol. 161 (1), pp. 328-329. Date of Electronic Publication: 2021 Feb 05.
DOI: 10.1016/j.ygyno.2021.01.032
Databáze: MEDLINE